![Stefan Luzi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stefan Luzi
Direttore/Membro del Consiglio presso
Amphista Therapeutics Ltd.
Profilo
Stefan Luzi currently works at Amphista Therapeutics Ltd., as Non-Executive Director and Gilde Healthcare Partners BV, as Partner from 2017.
Dr. Luzi also formerly worked at LAVA Therapeutics NV, as Non-Executive Director from 2021 to 2023 and Draupnir Bio ApS, as Director.
Dr. Luzi received his graduate degree in 2009 and doctorate degree in 2013 from the University of Cambridge and undergraduate degree in 2006 and graduate degree in 2008 from Swiss Federal Institute of Technology.
Posizioni attive di Stefan Luzi
| Società | Posizione | Inizio |
|---|---|---|
Gilde Healthcare Partners BV
 Gilde Healthcare Partners BV Investment ManagersFinance Gilde Healthcare Partners invests in lower middle market companies located in North America and Europe with an EBITDA of EUR 3 -20 million. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed, early, later, buyout and growth stage capital requirements with an investment size of EUR 50 million. It takes both minority and majority positions. | Investitore di Private Equity | 01/08/2017 |
Amphista Therapeutics Ltd.
 Amphista Therapeutics Ltd. BiotechnologyHealth Technology Develops biotechnology products | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Stefan Luzi
| Società | Posizione | Fine |
|---|---|---|
| LAVA THERAPEUTICS | Direttore/Membro del Consiglio | 09/03/2023 |
Draupnir Bio ApS
 Draupnir Bio ApS BiotechnologyHealth Technology Operates as a biotechnology company that develops oral and small molecule degraders of extracellular diseases | Direttore/Membro del Consiglio | - |
Formazione di Stefan Luzi
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
89
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swiss Federal Institute of Technology
 Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gilde Healthcare Partners BV
Gilde Healthcare Partners BV Investment ManagersFinance Gilde Healthcare Partners invests in lower middle market companies located in North America and Europe with an EBITDA of EUR 3 -20 million. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed, early, later, buyout and growth stage capital requirements with an investment size of EUR 50 million. It takes both minority and majority positions. | Finance |
LAVA Therapeutics NV
 LAVA Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops antibodies for the treatment of cancer | Health Technology |
Amphista Therapeutics Ltd.
Amphista Therapeutics Ltd. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
Draupnir Bio ApS
Draupnir Bio ApS BiotechnologyHealth Technology Operates as a biotechnology company that develops oral and small molecule degraders of extracellular diseases | Health Technology |
